Exo Therapeutics
Pre-clinicalDevelops small molecule drugs targeting exosites to treat diseases with high unmet medical need.
Founded
2017
Focus
Small Molecules
About
Develops small molecule drugs targeting exosites to treat diseases with high unmet medical need.
Funding History
2Total raised: $160M
Series B$82MNovo HoldingsJun 15, 2022
Series A$78MNovo HoldingsOct 15, 2020
Company Info
TypePrivate
Founded2017
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile